The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index; 39 of the 96 sources its claims cite were checked for support.
Bidirectional brain-gut axis effects influence mood and prognosis in IBD: A systematic review and meta-analysis
Abstract
OBJECTIVE: The role of the brain-gut axis is of increasing interest in IBD, as the link between common mental disorders and GI inflammation may be bidirectional. We performed a systematic review examining these issues. DESIGN: We searched EMBASE Classic and EMBASE, Medline, and APA PsychInfo (to 11 July 2021) for longitudinal follow-up studies examining effect of symptoms of anxiety or depression on subsequent adverse outcomes in IBD, or effect of active IBD on subsequent development of symptoms of anxiety or depression. We pooled relative risks (RRs) and HRs with 95% CIs for adverse outcomes (flare, escalation of therapy, hospitalisation, emergency department attendance, surgery or a composite of any of these) according to presence of symptoms of anxiety or depression at baseline, or RRs and HRs with 95% CIs for new onset of symptoms of anxiety or depression according to presence of active IBD at baseline. RESULTS: We included 12 separate studies, recruiting 9192 patients. All 12 studies examined brain-to-gut effects. Anxiety at baseline was associated with significantly higher risks of escalation of therapy (RR=1.68; 95% CI 1.18 to 2.40), hospitalisation (RR=1.72; 95% CI 1.01 to 2.95), emergency department attendance (RR=1.30; 95% CI 1.21 to 1.39), or a composite of any adverse outcome. Depression at baseline was associated with higher risks of flare (RR=1.60; 95% CI 1.21 to 2.12), escalation of therapy (RR=1.41; 95% CI 1.08 to 1.84), hospitalisation (RR=1.35; 95% CI 1.17 to 1.57), emergency department attendance (RR=1.38; 95% CI 1.22 to 1.56), surgery (RR=1.63; 95% CI 1.19 to 2.22) or a composite of any of these. Three studies examined gut-to-brain effects. Active disease at baseline was associated with future development of anxiety or depression (RR=2.24; 95% CI 1.25 to 4.01 and RR=1.49; 95% CI 1.11 to 1.98, respectively). CONCLUSION: Bidirectional effects of the brain-gut axis are present in IBD and may influence both the natural history of the disease and psychological health.
Overview
CoChat Summary
## TL;DR
This systematic review and meta-analysis found bi-directional brain-gut axis effects in inflammatory bowel disease (IBD): baseline anxiety or depression predicted worse later IBD outcomes, and active IBD predicted later anxiety or depression. The review included 13 longitudinal studies (12 separate populations) and 9192 patients.
## Key findings
- The search identified 17,928 citations; 124 were reviewed in full, and 13 eligible articles reported on 12 separate study populations with 9192 patients.
- In brain-to-gut analyses, baseline anxiety was associated with higher risks of escalation of therapy (RR 1.68; 95% CI 1.18-2.40), hospitalisation (RR 1.72; 95% CI 1.01-2.95), emergency department attendance (RR 1.30; 95% CI 1.21-1.39), and a composite outcome (RR 1.21; 95% CI 1.08-1.36).
- Baseline depression was associated with higher risks of flare (RR 1.60; 95% CI 1.21-2.12), escalation of therapy (RR 1.41; 95% CI 1.08-1.84), hospitalisation (RR 1.35; 95% CI 1.17-1.57), emergency department attendance (RR 1.38; 95% CI 1.22-1.56), IBD-related surgery (RR 1.63; 95% CI 1.19-2.22), and a composite endpoint (RR 1.26; 95% CI 1.07-1.48).
- In gut-to-brain analyses, clinically active disease at baseline predicted later anxiety (RR 2.24; 95% CI 1.25-4.01; n=249) and depression (RR 1.49; 95% CI 1.11-1.98; n=642).
## Methods
- Systematic review and meta-analysis of longitudinal follow-up studies from EMBASE Classic, EMBASE, MEDLINE, and APA PsychInfo searched to July 11, 2021.
- Included adult IBD studies with ≥50 participants, at least two follow-up time points separated by ≥6 months, and validated measures of anxiety/depression or IBD activity at baseline.
- Pooled RRs and HRs using an inverse-variance random-effects model; heterogeneity was assessed with I² and the χ² test.
## Limitations
- The paper states the evidence was limited by a relatively small number of eligible studies, variable quality, and significant heterogeneity in some analyses; it also notes too few studies to explore sources of heterogeneity or to assess publication bias.
- The authors state that many studies had short follow-up (four had 12 months or less), which may be too brief for some endpoints.
- Evident from the text: all eligible studies were conducted in hospital settings and mostly in North America, Europe, or Australia, so the findings may not generalize to community settings or other regions; the paper also says data were insufficient to compare effects by Crohn’s disease vs ulcerative colitis.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 8 Not valid · 21 Not checked · 54 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“When data were pooled from five studies,[20, 26, 27, 29, 30] containing 1244 patients, the risk of developing a flare of disease activity was no higher among those with symptoms of anxiety at baseline (RR = 1.20; 95% CI 0.93-1.55), with moderate heterogeneity between studies ( I 2 =53.7%).”
What the sources say
- Not checked yetcites [20] source
- Partly supportedcites [26] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Disputedcites [27] Marrie, 2021, The relationship between symptoms of depression and anxiety and disease activity in IBD over time, Inflamm Bowel Dis sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 0 partially supported, 2 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
- Disputedcites [29] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 0 partially supported, 1 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
- Disputedcites [30] Narula, 2019, Anxiety but not depression predicts poor outcomes in inflammatory bowel disease, Inflamm Bowel Dis sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 0 partially supported, 1 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
plainn = 1,244- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Finally, four studies reported a composite endpoint of one or more of the above,[24, 26, 28, 30] recruiting 2906 patients. In those with symptoms of depression at baseline there was a significantly increased risk of one or more adverse outcomes, compared with those without (RR = 1.26; 95% CI 1.07-1.48; I 2 =19.8%) (Figure 3f).”
What the sources say
- Not checked yetcites [24] source
- Disputedcites [26] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 0 partially supported, 1 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
- Supportedcites [28] Mikocka-Walus, 2016, Symptoms of depression and anxiety are independently associated with clinical recurrence of inflammatory bowel disease, Clin Gastroenterol Hepatol source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Supportedcites [30] Narula, 2019, Anxiety but not depression predicts poor outcomes in inflammatory bowel disease, Inflamm Bowel Dis source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plainstates an associationn = 2,906 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Pooling data from four studies,[21, 22, 26, 27] containing 6957 patients, there was an increased risk of escalation of therapy due to uncontrolled IBD activity in those reporting symptoms of depression at baseline (RR = 1.41; 95% CI 1.08-1.84) (Figure 3b), with low heterogeneity ( I 2 =43.1%).”
What the sources say
- Not checked yetcites [21] Jordi, 2021, Depressive symptoms predict clinical recurrence of inflammatory bowel disease, Inflamm Bowel Dis
- Supportedcites [22] Kochar, 2018, Depression is associated with more aggressive inflammatory bowel disease, Am J Gastroenterol source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Disputedcites [26] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 0 partially supported, 1 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
- Partly supportedcites [27] Marrie, 2021, The relationship between symptoms of depression and anxiety and disease activity in IBD over time, Inflamm Bowel Dis sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
plainstates an associationn = 6,957 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“When data were pooled from three studies,[21, 22, 26] containing 6710 patients, IBD-related surgery was also significantly more likely among those with symptoms of depression at baseline (RR = 1.63; 95% CI 1.19-2.22) (Figure 3e), with moderate heterogeneity between studies ( I 2 =57.4%).”
What the sources say
- Not checked yetcites [21] Jordi, 2021, Depressive symptoms predict clinical recurrence of inflammatory bowel disease, Inflamm Bowel Dis
- Partly supportedcites [22] Kochar, 2018, Depression is associated with more aggressive inflammatory bowel disease, Am J Gastroenterol sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Disputedcites [26] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 0 partially supported, 2 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
plainstates an associationn = 6,710 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“When data were pooled from eight studies,[20-23, 26, 27, 29, 30] which included 7606 patients, symptoms of depression at baseline were associated with a significantly increased risk of flare of disease activity during longitudinal follow-up (RR = 1.60; 95% CI 1.212.12), with high heterogeneity between studies ( I 2 =73.5%)”
What the sources say
- Not checked yetcites [20] source
- Not checked yetcites [21] Jordi, 2021, Depressive symptoms predict clinical recurrence of inflammatory bowel disease, Inflamm Bowel Dis
- Disputedcites [22] Kochar, 2018, Depression is associated with more aggressive inflammatory bowel disease, Am J Gastroenterol sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 1 partially supported, 1 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
- Not checked yetcites [23] source
- Disputedcites [26] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 0 partially supported, 1 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
- Partly supportedcites [27] Marrie, 2021, The relationship between symptoms of depression and anxiety and disease activity in IBD over time, Inflamm Bowel Dis sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
- Disputedcites [29] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 0 partially supported, 1 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
- Disputedcites [30] Narula, 2019, Anxiety but not depression predicts poor outcomes in inflammatory bowel disease, Inflamm Bowel Dis sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 0 partially supported, 2 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
plainstates an associationn = 7,606- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
54 more claims · 8 with their cited sources checked
Create a free account to see all 91 claims and to verify the 57 references still open.
- Probably not a substantial claim. 15
- It may state two separate claims as one. 21
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prospective research has found a bidirectional relationship between increased distress and disease flare-ups, such that not only are flare-ups associated with experiencing depression/anxiety symptoms, but increased depression/anxiety symptoms are also a predictor of more frequent flare-ups.3,4”
From Feasibility, Acceptability, and Preliminary Efficacy of Acceptance Commitment Therapy for Adults Living With Inflammatory Bowel Disease and Distress. (2024) · cites this paper as [4]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“There is robust support for the detrimental effects of depression and anxiety on the subsequent course of IBD, based on longitudinal studies tracking outcomes over time (19).”
From The 2023 Impact of Inflammatory Bowel Disease in Canada: Mental Health and Inflammatory Bowel Disease (2023) · cites this paper as [19]
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
(2014) · Medical Entomology and Zoology · Cited by 17,633
Sterne, J. A. C., Sutton, A. J., Ioannidis, J. P. A., Terrin, N., Jones, D. R., Lau, J., Carpenter, J., Rucker, G., Harbord, R. M., Schmid, C. H., et al. (2011) · BMJ · doi:10.1136/bmj.d4002 · Cited by 7,709
Ng, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., Panaccione, R., Ghosh, S., Wu, J. C. Y., Chan, F. K. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32448-0 · Cited by 6,087
Zhang, J., & Yu, K. F. (1998) · JAMA · doi:10.1001/jama.280.19.1690 · Cited by 4,138
Barberio, B., Zamani, M., Black, C. J., Savarino, E. V., & Ford, A. C. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00014-5 · Cited by 758
Self-citationStress and Exacerbation in Ulcerative Colitis: A Prospective Study of Patients Enrolled in Remission
Levenstein, S., Prantera, C., Varvo, V., Scribano, M. L., Andreoli, A., Luzi, C., Arcà, M., Berto, E., Milite, G., & Marcheggiano, A. (2000) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.02012.x · Cited by 451
Bi-directionality of brain–gut interactions in patients with inflammatory bowel disease
Gracie, D. J., Guthrie, E. A., Hamlin, P. J., & Ford, A. C. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.01.027 · Cited by 408
Self-citation
Cited by
Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment
Bisgaard, T. H., Allin, K. H., Keefer, L., Ananthakrishnan, A. N., & Jess, T. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00634-6 · Cited by 572
Ge, L., Liu, S., Li, S., Yang, J., Hu, G., Xu, C., & Song, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1016578 · Cited by 187
ACG Clinical Guideline: Management of Crohn's Disease in Adults
Lichtenstein, G. R., Loftus, E. V., Afzali, A., Long, M. D., Barnes, E. L., Isaacs, K. L., & Ha, C. Y. (2025) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003465 · Cited by 209
Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting
Parigi, T. L., D’Amico, F., Abreu, M. T., Dignass, A. U., Dotan, I., Magro, F., Griffiths, A. M., Jairath, V., Iacucci, M., Mantzaris, G. J., et al. (2023) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(23)00154-1 · Cited by 156
Gut microbiome-mediated regulation of neuroinflammation
Bostick, J. W., Schonhoff, A. M., & Mazmanian, S. K. (2022) · Current Opinion in Immunology · doi:10.1016/j.coi.2022.102177 · Cited by 125
Metadata
- Authors
- Fairbrass, K. M., Lovatt, J., Barberio, B., Yuan, Y., Gracie, D. J., & Ford, A. C.
- Affiliations
- University of Leeds (GB)
- St James's University Hospital (GB)
- University of Padua (IT)
- McMaster University (CA)
- Corresponding author
- Ford, Alexander C
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2021-11-01
- Volume
- 71
- Issue
- 9
- Pages
- 1773-1780
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W3209431709
- Cited by
- 225
- References
- 49
- Citations by year
- 2026: 48 · 2025: 66 · 2024: 55 · 2023: 39 · 2022: 16 · 2021: 1
- FWCI
- 4.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gut (publishedVersion)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- gut-brain axis, inflammatory bowel disease, anxiety, depression, bidirectional effects, disease flares, treatment escalation, hospitalization, emergency department visits, prognosis, psychoneuroimmunology, gut microbiota, neuroimmune interactions, neuroinflammation
- MeSH terms
- Brain-Gut Axis, Anxiety, Follow-Up Studies, Humans, Prognosis, Inflammatory Bowel Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bidirectional brain-gut axis effects influence mood and prognosis in IBD: A systematic review and meta-analysis. https://app.cochat.ai/papers/10.1136/gutjnl-2021-325985
- The paper
- Fairbrass, K. M., Lovatt, J., Barberio, B., Yuan, Y., Gracie, D. J., & Ford, A. C. (2022). Bidirectional brain-gut axis effects influence mood and prognosis in IBD: A systematic review and meta-analysis. Gut. https://doi.org/10.1136/gutjnl-2021-325985
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.